MAD2 activates IGF1R/PI3K/AKT pathway and promotes cholangiocarcinoma progression by interfering USP44/LIMA1 complex-Reference-Cited by-同舟云学术

MAD2 activates IGF1R/PI3K/AKT pathway and promotes cholangiocarcinoma progression by interfering USP44/LIMA1 complex

Published:2023-09-26 Issue:45 Volume:42 Page:3344-3357
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Jiang Wangjie,Yang Xiao,Shi Kuangheng,Zhang Yaodong,Shi Xiaoli,Wang Jifei,Wang Yuming,Chenyan Anlan,Shan Jijun,Wang Yirui,Chang Jiang,Chen Ruixiang,Zhou Tao,Zhu Yanping,Yu Yue,Li Changxian^ORCID,Li Xiangcheng^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

https://www.nature.com/articles/s41388-023-02849-6.pdf

Reference36 articles.

1. Huang YH, Zhang CZ, Huang QS, Yeong J, Wang F, Yang X, et al. Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma. J Hepatol. 2021;74:838–49.

2. Hosokawa I, Hayano K, Furukawa K, Takayashiki T, Kuboki S, Takano S, et al. Preoperative diagnosis of lymph node metastasis of perihilar cholangiocarcinoma using diffusion-weighted magnetic resonance imaging. Ann Surg Oncol. 2022;29:5502–10.

3. Zhang XF, Xue F, Dong DH, Weiss M, Popescu I, Marques HP, et al. Number and station of lymph node metastasis after curative-intent resection of intrahepatic cholangiocarcinoma impact prognosis. Ann Surg. 2021;274:e1187–e1195.

4. Esnaola NF, Meyer JE, Karachristos A, Maranki JL, Camp ER, Denlinger CS. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma. Cancer. 2016;122:1349–69.

5. Rizvi S, Gores GJ. Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology. 2013;145:1215–29.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression and molecular insights of lima1 in cholangiocarcinoma;Cell Adhesion & Migration;2024-07-30

2. Chlorogenic Acid as a Potential Therapeutic Agent for Cholangiocarcinoma;Pharmaceuticals;2024-06-17

3. Exploring the Enigma: The Role of the Epithelial Protein Lost in Neoplasm in Normal Physiology and Cancer Pathogenesis;International Journal of Molecular Sciences;2024-05-02

4. 3-Methyladenine potentiates paclitaxel-induced apoptosis and phosphorylation of cyclin-dependent kinase 1 at thr161 in nasopharyngeal carcinoma cell;BIOCELL;2024